Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.-Q.
Right arrow Articles by Sarvetnick, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.-Q.
Right arrow Articles by Sarvetnick, N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2024-2033, 2004
© 2004 by the American Diabetes Association, Inc.

Inhibition of Activin Signaling Induces Pancreatic Epithelial Cell Expansion and Diminishes Terminal Differentiation of Pancreatic ß-Cells

You-Qing Zhang1, Mary Malo Cleary1, Yingjie Si1, Guoxun Liu1, Yuzuru Eto2, Marcie Kritzik1, Sandrine Dabernat1, Ayse G. Kayali1, and Nora Sarvetnick1

1 Department of Immunology, The Scripps Research Institute, La Jolla, California
2 Pharmaceutical Research Laboratories, Ajinomoto Co., Kawasaki, Japan

Activins regulate the growth and differentiation of a variety of cells. During pancreatic islet development, activins are required for the specialization of pancreatic precursors from the gut endoderm during midgestation. In this study, we probed the role of activin signaling during pancreatic islet cell development and regeneration. Indeed, we found that both activins and activin receptors are upregulated in duct epithelial cells during islet differentiation. Interestingly, the expression of endogenous cellular inhibitors of activin signaling, follistatin and Cripto, were also found to be augmented. Inhibition of activins significantly enhanced survival and expansion of pancreatic epithelial cells but decreased the numbers of differentiated ß-cells. Our results suggest that the homeostasis of growth and terminal differentiation requires a precise context-dependent regulation of activin signaling. Follistatin participates in this process by promoting expansion of precursor cells during pancreas growth.


Address correspondence and reprint requests to Nora Sarvetnick, PhD, Department of Immunology, IMM23, The Scripps Research Institute, La Jolla, CA 92037. E-mail: noras{at}scripps.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
M. Eijken, S. Swagemakers, M. Koedam, C. Steenbergen, P. Derkx, A. G. Uitterlinden, P. J. van der Spek, J. A. Visser, F. H. de Jong, H. A. P. Pols, et al.
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization
FASEB J, September 1, 2007; 21(11): 2949 - 2960.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. M. Simeone, L. Zhang, M. K. Treutelaar, L. Zhang, K. Graziano, C. D. Logsdon, and C. F. Burant
Islet hypertrophy following pancreatic disruption of Smad4 signaling
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1305 - E1316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hua, Y.-Q. Zhang, S. Dabernat, M. Kritzik, D. Dietz, L. Sterling, and N. Sarvetnick
BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2
J. Biol. Chem., May 12, 2006; 281(19): 13574 - 13580.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. P. Chute, G. G. Muramoto, H. K. Dressman, G. Wolfe, N. J. Chao, and S. Lin
Molecular Profile and Partial Functional Analysis of Novel Endothelial Cell-Derived Growth Factors that Regulate Hematopoiesis
Stem Cells, May 1, 2006; 24(5): 1315 - 1327.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
E. B. Harmon, A. A. Apelqvist, N. G. Smart, X. Gu, D. H. Osborne, and S. K. Kim
GDF11 modulates NGN3+ islet progenitor cell number and promotes {beta}-cell differentiation in pancreas development
Development, December 15, 2004; 131(24): 6163 - 6174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.